Canada-based University of Waterloo’s systems design engineering professor Alexander Wong has developed a new imaging technique called correlated diffusion imaging (CDI) to assess the impact of Covid-19 on the brain.
CDI is a new form of magnetic resonance imaging (MRI) designed to capture and mix MRI signals at different gradient pulse strengths and timings to better show the differences in the way water molecules move in tissue.
Go deeper with GlobalData
Earlier, Wong developed CDI to provide a better imaging measure for identifying cancer. This new technique has been used in a study conducted at Baycrest’s Rotman Research Institute and Sunnybrook Hospital in Toronto.
Wong and his student Hayden Gunraj are the co-authors of the study named “Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: Application in Covid-19”.
The rendering of the frontal-lobe white matter’s CDI showed a less-restricted diffusion of water molecules in patients with Covid-19.
Simultaneously, the imaging demonstrated a restricted diffusion of water molecules in the cerebellum of Covid-19 patients.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataRotman’s study is claimed to be the first one to show diffusion abnormalities in the white matter of the cerebellum, in addition to demonstrating Covid-19’s effects on the brain.
Wong suggested that future tests will study whether Covid-19 actually damages brain tissue.
Additional studies will be conducted to determine whether Covid-19 can change the grey matter of the brain.
Wong said: “Hopefully, this research can lead to better diagnoses and treatments for Covid-19 patients.
“And that could just be the beginning for CDI, as it might be used to understand degenerative processes in other diseases such as Alzheimer’s or to detect breast or prostate cancers.”
